You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

828 Results
Document
Nov 2020
Document
Nov 2020
Document
Nov 2020
Document
Nov 2020
Document
Nov 2020
Statistical Reports
*/ For the most recent data, refer to the Ontario Cancer Screening Performance Report 2023. Effective cancer screening through organized...
Nov 2020
Document
Dec 2020
Document
Dec 2020
Document
Dec 2020
Document
Dec 2020
Regimen
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's Intermediate Grade
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Funding:
ODB - General Benefit
    procarbazine
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
riTUXimab (Unfunded),
methotrexate,
procarbazine,
cytarabine
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Dec 2020
Document
Dec 2020

Pages